Search
for
Sort by
Research 61–90 of 1000+
- Behcet's disease and complex aphthosis
- Top applications of dermatologic ultrasonography that can modify management
- Cutaneous manifestations of endocrine diseases in children
- Chronic graft versus host disease and skin
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Dermatological aspects of synthetic cannabinoid addiction
- Presence and future of dermoscopy
- “PRIDE” Complex
- An Unusual Case of Diarrhea, Dysgeusia, and Grainy and Nodular Mucosa
- Dermatological history and examination
- Contents
- A Clinicopathological and Immunofluorescence study of Lichen Planus
- Nail Involvement in Pediatric Alopecia Areata: Clinical and Onychoscopic Features: A Serie of 42 Cases
- Hair and Nail Relationship
- Periungual lesions secondary to chemotherapy with docetaxel
- Dermoscopic Assessment of Nail Alterations in Egyptian Patients with Alopecia Areata
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Cutaneous Lesions in Systemic Lupus Erythematosus
- Unraveling the Molecular Mechanisms of Hair and Nail Genodermatoses
- Heterogeneous red–white discoloration of the nail bed and distal onycholysis in a patient with COVID‐19
- “Nail loss after teriflunomide treatment: A new potential adverse event”
- Normal Ultrasound Anatomy of the Skin, Nail, and Hair
- Familial Pure Hair–Nail Ectodermal Dysplasia in Yemen: A Father–Son Case Report with Clinical Correlation
- A Case of Idiopathic Twenty-Nail Dystrophy
- Abemaciclib-Associated Skin, Hair, and Nail Toxicities: A Case Report
- Nail Whispers Revealing Dermatological and Systemic Secrets: An Analysis of Nail Disorders Associated With Diverse Dermatological and Systemic Conditions
- Nail and hair changes in chronic kidney disease patients
- British Hair and Nail Society
- Relapsing nail fibrokeratoma: A case report on a teenager
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment